Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol

Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol

US Patent 11116721 · Granted Sep 14, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combinations of a muscarinic receptor antagonist and a β-2 adrenoreceptor agonis2025
Combinations of a muscarinic receptor antagonist and a β-2 adrenoreceptor agonis2025
Combinations of a muscarinic receptor antagonist and a β-2 adrenoreceptor agonis2025
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor ago2021
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor ago2021
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor ago2021
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor ago2017
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor ago2017
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor ago2017
Skimmer door assembly2008
Variable restriction1995